LEAF-1703

N/A

Report date: 2025/01/26 17:49:48
NME

Base Information

Drug NameLEAF-1703
Drug Alias Nameserine-glycine-one-carbon metabolic pathway modulator (L.E.A.F Pharmaceuticals)LEAF-1703
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsHead and Neck NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesL.E.A.F. Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesL.E.A.F. Pharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A